A bioreducible linear poly(β-amino ester) for siRNA delivery

Area of Science:

• Biomaterials Science
• Nanotechnology
• Gene Therapy

Background:

• siRNA (small interfering RNA) holds promise for gene silencing therapies but requires effective delivery systems.
• Developing safe and efficient carriers for siRNA is crucial for therapeutic applications.
• Cytoplasmic release of siRNA post-delivery is essential for its biological activity.

Purpose of the Study:

• To synthesize and characterize a novel bioreducible linear poly(β-amino ester).
• To evaluate the polymer's ability to condense siRNA into nanoparticles.
• To assess the efficiency of siRNA release in the cytoplasm and its therapeutic effect in glioblastoma cells.

Main Methods:

• Synthesis of a bioreducible linear poly(β-amino ester).
• Formation of siRNA-loaded nanoparticles using the synthesized polymer.
• In vitro evaluation of nanoparticle cytotoxicity in primary human glioblastoma cells.
• Assessment of gene knockdown efficacy using a fluorescent marker gene.

Main Results:

• The novel poly(β-amino ester) was successfully synthesized and characterized.
• The polymer effectively condensed siRNA into nanoparticles.
• siRNA delivery via these nanoparticles resulted in near-complete knockdown of the target gene.
• No significant cytotoxicity was observed in the treated glioblastoma cells.

Conclusions:

• The developed bioreducible polymer is a promising non-cytotoxic vehicle for siRNA delivery.
• Efficient cytoplasmic release and gene silencing were achieved in human glioblastoma cells.
• This polymer represents a potential advancement in siRNA-based therapeutic strategies for cancer.